By The Numbers
- Dell Has Worst Day in 11 Years, Volume Jumps
- What Would it Take for Facebook to Eclipse Visa's Record IPO?
- Gold Turns Negative for 2012
- The Worst-Performing Energy Stocks This Week
- Papa Johns Hits Record High, Volume Spikes
- S&P 500 Earnings: Biggest Surprises
- Big Lots Has Worst Day Since 2008, Breaks Technical Level
- BP Oil Disaster: Two Years Later
- eBay Has Best Day Since 2008, Volume Spikes
- Here are Today's Winners on the Biotech Index
EDITOR
ABOUT BY THE NUMBERS
Our market specialists dig deep into Wall Street’s daily metrics, crunching the numbers to help you become smarter about the market so that you can make better investment decisions. By The Numbers details the daily drama, the winners and losers, how the day stacks up historically, and how the numbers can offer a glimpse of the future.
#GIOVANNYMOREANO ON TWITTER
5 Healthcare Stocks to Watch
Published:
Tuesday, 28 Jul 2009 | 9:56 AM ET
Text Size 
By: Ariel Nelson
Director of Market Data & Content Services
Director of Market Data & Content Services
Healthcare is cruising along this earnings season. So far this quarter, only one S&P healthcare company, Aetna [AET
Loading...
()
], has missed its consensus EPS estimate. Yesterday after the bell Amgen [AMGN
Loading...
()
] blew the cover off the ball with a 40% rise in earnings and this morning, Teva Pharmaceuticals [TEVA
Loading...
()
] beat by three cents per share. This week there are over 20 more healthcare companies reporting; here are some to watch.
Today, July 28
- Teva - Reported this morning. The world's largest generic drug maker beat the street this morning and is trading at an all time high. That is now 10 straight quarters of beating the street. The company now sees 2010 growth at 35%.
- McKesson [MCK
Loading...
()
] - Reports after the bell. This drug distributor is trading at levels not seen last October. It has only missed analyst consensus numbers once in the past 16 quarters and the company was upgraded yesterday by Raymond James.
Tomorrow, July 29
- Medco [MHS
Loading...
()
] - Reports before the bell. This pharmaceutical benefits manager (PBM) is trading at a new 52-week high. It has beaten analyst consensus numbers in the past 10 straight quarters. Could be a potential buyer of Aetna's PBM business.
- Wellpoint [WLP
Loading...
()
] - Reports before the bell. This health insurer is near its 52-week high. It has beaten analyst consensus numbers in 5 of the past 7 quarters. Watch the numbers to see if Aetna's miss was an exception or will hit other insurers too.
- Express Scripts [ESRX
Loading...
()
] - Reports after the bell. This PBM is also hitting price levels it has not seen since October and is another potential buyer of Aetna's PBM business. It has beaten analyst consensus numbers in 12 of the past 13 quarters and has earnings growth forecast for 2010 of nearly 22%.
Comments? Send them to
© 2012 CNBC.com
- The Nasdaq has suffered the most from the EU crisis showing there's risk in the usual tech stocks.
- Targeting more Millennials is just one of the items brewing for consumers in the world of spirits.
- It seems many people may need a reminder of how NOT to act on a plane. Here are a few tips.
- Here are some very unusual roadside stops along American highways that might peek your interest.
- How three generations of Americans are dealing with the finances of retirement.
Data is a real-time snapshot *Data is delayed at least 15 minutes
